Clinical trials with MRNA electroporated dendritic cells for stage III/IV melanoma patients

Samankaltaisia teoksia

• Phase II study of autologous mRNA electroporated dendritic cells (TriMixDC-MEL) in combination with Ipilimumab in patients with pretreated advanced melanoma
  Tekijä: Thielemans, Kris, et al.
  Julkaistu: (2014)
• Characterization of CD8(+) T-Cell Responses in the Peripheral Blood and Skin Injection Sites of Melanoma Patients Treated with mRNA Electroporated Autologous Dendritic Cells (TriMixDC-MEL)
  Tekijä: Benteyn, Daphné, et al.
  Julkaistu: (2013)
• TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma
  Tekijä: De Keersmaecker, Brenda, et al.
  Julkaistu: (2020)
• Dendritic Cells Loaded With mRNA Encoding Full-length Tumor Antigens Prime CD4(+) and CD8(+) T Cells in Melanoma Patients
  Tekijä: Van Nuffel, An MT, et al.
  Julkaistu: (2012)
• AZD1480 delays tumor growth in a melanoma model while enhancing the suppressive activity of myeloid-derived suppressor cells
  Tekijä: Maenhout, Sarah K., et al.
  Julkaistu: (2014)